Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Karen Sims currently holds 125,542 shares of Arbutus Biopharma Corp (ABUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen Sims has been a net seller of ABUS stock. They have purchased $0 and sold $10.1K worth of shares.
Karen Sims's most recent insider trade was on Feb 2, 2024, when they sold 4,358 shares at $2.31 per share.
Karen Sims serves as Executive at Arbutus Biopharma Corp (ABUS). They have executed 3 insider transactions totaling $10.1K over their tenure at the company.
Karen Sims holds the position of Executive at Arbutus Biopharma Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Karen Sims has shown a selling trading pattern, with $0 in total purchases and $10.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Karen Sims was on Feb 2, 2024, when they sold $10.1K worth of ABUS shares. This transaction involved 4,358 shares at $2.31 per share.
Karen Sims currently owns 125,542 shares of Arbutus Biopharma Corp (ABUS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Karen Sims's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Karen Sims has 3 Form 4 filings on record as an insider at Arbutus Biopharma Corp.
Set alerts for Karen Sims and 40,000+ other insiders.